ARTICLE | Company News
Takeda submits Japanese NDA for once-weekly DPP-4 inhibitor
March 8, 2014 12:43 AM UTC
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for trelagliptin ( SYR-472) to treat Type II diabetes. The once-weekly oral dipepti...